Pricing Log in Create free account

GH Research PLC (GHRS) vs Nektar Therapeutics (NKTR)

GH Research PLC and Nektar Therapeutics are both Biotechnology companies. GH Research PLC and Nektar Therapeutics are of similar size ($1.3B and $1.3B). GH Research PLC has the higher net margin (0.00% vs −287.8%) and the higher return on invested capital (0.00% vs −40.2%). Across the 13 metrics below, GH Research PLC leads on 10 and Nektar Therapeutics on 3.

Valuation

Metric GHRS NKTR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 21.67 9.71
P/B 3.36 1.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 18.33 9.21
Earnings yield (5.51%) (18.73%) (33.15%)
Free cash flow yield (4.29%) (19.79%) (25.50%)

Profitability

Metric GHRS NKTR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (257.80%) 0.00%
Net margin 0.00% (287.84%) 0.00%
Free cash flow margin 0.00% (428.72%) 0.00%
Return on equity (18.79%) (35.75%) (56.36%)
Return on assets (18.16%) (24.12%) (48.04%)
Return on invested capital 0.00% (40.20%) 0.00%

Growth

Metric GHRS NKTR Biotechnology median
Revenue growth (TTM) — (27.15%) 6.02%
EPS growth (last fiscal year) (5.33%) (11.89%) 30.26%
Revenue growth, 5-year CAGR — (18.43%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GHRS NKTR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 28.70 10.42 4.72
Net debt to EBITDA 4.65 1.77 0.96

Dividend

Metric GHRS NKTR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GHRS NKTR Biotechnology median
Market cap 1.29b 1.29b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack